Genetic Variation Of Enzyme Linked With Outcomes For Women Receiving Tamoxifen, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Study
EurekAlert! -- Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.